Trials / Terminated
TerminatedNCT00649220
Memantine and Antipsychotics Use
Prospective, Single-arm, Multi-centre, Open-label Study to Investigate the Potential to Reduce Concomitant Antipsychotics Use in Patients With Moderate to Severe Dementia of Alzheimer's Type (DAT) Treated With Memantine
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Merz Pharmaceuticals GmbH · Industry
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the potential to reduce concomitant antipsychotic medication use in subjects with moderate dementia of Alzheimer's type, treated with memantine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Memantine | memantine tablets, twice a day (bid), for 20 weeks |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-05-01
- Completion
- 2009-06-01
- First posted
- 2008-04-01
- Last updated
- 2011-09-26
- Results posted
- 2011-09-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00649220. Inclusion in this directory is not an endorsement.